The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| ABBOTT LABORATORIES | Equity | 002824100 | 6,857 | 75,000 | SH | SOLE | 75,000 | 0 | 0 | ||
| AMYRIS INC | Equity | 03236M200 | 5,693 | 1,333,333 | SH | SOLE | 1,333,333 | 0 | 0 | ||
| ATRICURE INC | Equity | 04963C209 | 10,114 | 225,000 | SH | SOLE | 225,000 | 0 | 0 | ||
| BIO-RAD LABORATORIES-A | Equity | 090572207 | 13,545 | 30,000 | SH | SOLE | 30,000 | 0 | 0 | ||
| QUEST DIAGNOSTICS INC | Equity | 74834L100 | 31,339 | 275,000 | SH | SOLE | 275,000 | 0 | 0 | ||
| GLD US 01/15/21 C150 | Listed Option | 78463V907 | 8,208 | 4,000 | SH | Call | SOLE | 4,000 | 0 | 0 | |
| GW PHARMACEUTICALS -ADR | Depository Receipt | 36197T103 | 11,045 | 90,000 | SH | SOLE | 90,000 | 0 | 0 | ||
| HOLOGIC INC | Equity | 436440101 | 18,525 | 325,000 | SH | SOLE | 325,000 | 0 | 0 | ||
| ICU MEDICAL INC | Equity | 44930G107 | 14,376 | 78,000 | SH | SOLE | 78,000 | 0 | 0 | ||
| IVERIC BIO INC | Equity | 46583P102 | 5,100 | 1,000,000 | SH | SOLE | 1,000,000 | 0 | 0 | ||
| LABORATORY CRP OF AMER HLDGS | Equity | 50540R409 | 9,136 | 55,000 | SH | SOLE | 55,000 | 0 | 0 | ||
| LANTHEUS HOLDINGS INC | Equity | 516544103 | 13,585 | 950,000 | SH | SOLE | 950,000 | 0 | 0 | ||
| ALLSCRIPTS HEALTHCARE SOLUTI | Equity | 01988P108 | 10,832 | 1,600,000 | SH | SOLE | 1,600,000 | 0 | 0 | ||
| MEDTRONIC PLC | Equity | 585055106 | 13,755 | 150,000 | SH | SOLE | 150,000 | 0 | 0 | ||
| MISONIX INC | Equity | 604871103 | 4,370 | 322,041 | SH | SOLE | 322,041 | 0 | 0 | ||
| MYLAN NV | Equity | 628530107 | 6,432 | 400,000 | SH | SOLE | 400,000 | 0 | 0 | ||
| NATERA INC | Equity | 632307104 | 2,992 | 60,000 | SH | SOLE | 60,000 | 0 | 0 | ||
| NUANCE COMMUNICATIONS INC | Equity | 67020Y100 | 14,550 | 575,000 | SH | SOLE | 575,000 | 0 | 0 | ||
| OPTINOSE INC | Equity | 68404V100 | 11,346 | 1,525,000 | SH | SOLE | 1,525,000 | 0 | 0 | ||
| PACIRA BIOSCIENCES INC | Equity | 695127100 | 36,729 | 700,000 | SH | SOLE | 700,000 | 0 | 0 | ||
| PHREESIA INC | Equity | 71944F106 | 11,312 | 400,000 | SH | SOLE | 400,000 | 0 | 0 | ||
| PLEXUS CORP | Equity | 729132100 | 4,657 | 66,000 | SH | SOLE | 66,000 | 0 | 0 | ||
| PERRIGO CO PLC | Equity | G97822103 | 26,253 | 475,000 | SH | SOLE | 475,000 | 0 | 0 | ||
| RADNET INC | Equity | 750491102 | 11,109 | 700,000 | SH | SOLE | 700,000 | 0 | 0 | ||
| RIGEL PHARMACEUTICALS INC | Equity | 766559603 | 12,536 | 6,850,000 | SH | SOLE | 6,850,000 | 0 | 0 | ||
| SI-BONE INC | Equity | 825704109 | 1,677 | 105,200 | SH | SOLE | 105,200 | 0 | 0 | ||
| SPY US 07/17/20 P290 | Listed Option | 78462F953 | 896 | 4,000 | SH | Put | SOLE | 4,000 | 0 | 0 | |
| STREAMLINE HEALTH SOLUTIONS | Equity | 86323X106 | 5,727 | 4,305,882 | SH | SOLE | 4,305,882 | 0 | 0 | ||
| TEVA PHARMACEUTICAL-SP ADR | Depository Receipt | 881624209 | 3,083 | 250,000 | SH | SOLE | 250,000 | 0 | 0 | ||
| TEVA US 09/18/20 C10 | Listed Option | 881624909 | 1,625 | 6,500 | SH | Call | SOLE | 6,500 | 0 | 0 | |
| UNITEDHEALTH GROUP INC | Equity | 91324P102 | 10,323 | 35,000 | SH | SOLE | 35,000 | 0 | 0 | ||
| UNITED THERAPEUTICS CORP | Equity | 91307C102 | 21,175 | 175,000 | SH | SOLE | 175,000 | 0 | 0 | ||
| XBI US 07/17/20 P105 | Listed Option | 78464A950 | 274 | 2,000 | SH | Put | SOLE | 2,000 | 0 | 0 | |